BE841811A - Vaccin contre l'hepatite b - Google Patents
Vaccin contre l'hepatite bInfo
- Publication number
- BE841811A BE841811A BE167016A BE167016A BE841811A BE 841811 A BE841811 A BE 841811A BE 167016 A BE167016 A BE 167016A BE 167016 A BE167016 A BE 167016A BE 841811 A BE841811 A BE 841811A
- Authority
- BE
- Belgium
- Prior art keywords
- vaccine
- hepatitis
- Prior art date
Links
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/577,483 US4017360A (en) | 1975-05-14 | 1975-05-14 | Method for purifying hepatitis B antigen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE841811A true BE841811A (fr) | 1976-11-16 |
Family
ID=24308922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE167016A BE841811A (fr) | 1975-05-14 | 1976-05-13 | Vaccin contre l'hepatite b |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4017360A (fr) |
| JP (2) | JPS51139619A (fr) |
| AU (1) | AU504454B2 (fr) |
| BE (1) | BE841811A (fr) |
| CA (1) | CA1066191A (fr) |
| CH (1) | CH629668A5 (fr) |
| CY (1) | CY1034A (fr) |
| DE (1) | DE2621276A1 (fr) |
| DK (1) | DK145347C (fr) |
| ES (1) | ES447858A1 (fr) |
| FR (1) | FR2315947A1 (fr) |
| GB (1) | GB1488774A (fr) |
| HK (1) | HK86779A (fr) |
| NL (1) | NL188621C (fr) |
| SE (1) | SE431161B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE437329B (sv) * | 1975-03-14 | 1985-02-25 | Community Blood Council | Sett att ur blodserum framstella vaccin mot virushepatit |
| US4129646A (en) * | 1976-11-02 | 1978-12-12 | Merck & Co., Inc. | Isolating hepatitis B Dane particles |
| GB1554811A (en) * | 1977-02-23 | 1979-10-31 | Merck & Co Inc | Purifying hepatitis b surface antigen |
| US4217418A (en) * | 1978-05-08 | 1980-08-12 | Merck & Co., Inc. | Recovery of small particles by flow centrifugation |
| ATE1882T1 (de) * | 1978-05-08 | 1982-12-15 | Merck & Co. Inc. | Ein verfahren zur direkten extraktion von kleinen teilchen bis 50 nm aus einer proteinhaltigen fluessigkeit. |
| ZA792485B (en) * | 1978-06-07 | 1980-06-25 | New York Blood Center Inc | Vaccine for active immunization containing hepatitis b surface and/or e-antigens |
| US4181713A (en) * | 1978-10-30 | 1980-01-01 | Merck & Co., Inc. | Isolation of HBs Ag |
| US4395395A (en) * | 1979-05-21 | 1983-07-26 | The United States Of America As Represented By The Department Of Health And Human Services | Detection of non-A, non-B hepatitis associated antigen |
| DE2935634C2 (de) * | 1979-09-04 | 1981-12-10 | Battelle-Institut E.V., 6000 Frankfurt | Tiermodell zur Prüfung der Inaktivierung von Impfstoffen gegen Virushepatitis Typ B und zur Prüfung von Chemotherapeutika gegen Virushepatitis Typ A |
| FR2470795A1 (fr) * | 1979-12-07 | 1981-06-12 | Pasteur Institut | Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus |
| US4349539A (en) * | 1980-08-15 | 1982-09-14 | Merck & Co., Inc. | Separation of hepatitis B surface antigen |
| PL133476B1 (en) * | 1981-06-10 | 1985-06-29 | Akad Medyczna | Method of obtaining pure antigen hba from human serum |
| AU8746582A (en) * | 1981-09-02 | 1983-03-10 | Biogen N.V. | Hepatitis b virus e type antigen |
| GB8321789D0 (en) * | 1983-08-12 | 1983-09-14 | Biogen Nv | Vaccines and compositions against hepatitis |
| US4639371A (en) * | 1984-10-02 | 1987-01-27 | New York Blood Center, Inc. | Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom |
| JPS61158798A (ja) * | 1984-12-28 | 1986-07-18 | Japan Found Cancer Res | Ｂ型肝炎ウイルス表面抗原の製造法 |
| US5026828A (en) * | 1987-02-27 | 1991-06-25 | Merck & Co., Inc. | Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast |
| JPS63246335A (ja) * | 1987-09-17 | 1988-10-13 | メルク エンド カムパニー インコーポレーテツド | 肝炎ｂ抗原 |
| US5030720A (en) * | 1988-09-01 | 1991-07-09 | Merck & Co., Inc. | Pres2+S hepatitis B vaccine derived from plasma |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636191A (en) * | 1969-10-08 | 1972-01-18 | Cancer Res Inst | Vaccine against viral hepatitis and process |
| JPS5523254B2 (fr) * | 1974-01-28 | 1980-06-21 |
-
1975
- 1975-05-14 US US05/577,483 patent/US4017360A/en not_active Expired - Lifetime
-
1976
- 1976-04-26 NL NLAANVRAGE7604429,A patent/NL188621C/xx not_active IP Right Cessation
- 1976-04-27 SE SE7604818A patent/SE431161B/xx not_active IP Right Cessation
- 1976-04-28 DK DK190776A patent/DK145347C/da not_active IP Right Cessation
- 1976-05-04 CA CA251,740A patent/CA1066191A/fr not_active Expired
- 1976-05-04 GB GB18194/76A patent/GB1488774A/en not_active Expired
- 1976-05-04 AU AU13619/76A patent/AU504454B2/en not_active Expired
- 1976-05-04 CY CY1034A patent/CY1034A/xx unknown
- 1976-05-11 FR FR7614109A patent/FR2315947A1/fr active Granted
- 1976-05-12 ES ES447858A patent/ES447858A1/es not_active Expired
- 1976-05-13 BE BE167016A patent/BE841811A/fr not_active IP Right Cessation
- 1976-05-13 DE DE19762621276 patent/DE2621276A1/de active Granted
- 1976-05-14 CH CH607776A patent/CH629668A5/de not_active IP Right Cessation
- 1976-05-14 JP JP51054486A patent/JPS51139619A/ja active Granted
-
1979
- 1979-12-20 HK HK867/79A patent/HK86779A/xx unknown
-
1983
- 1983-02-24 JP JP58028652A patent/JPS58180432A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| SE7604818L (sv) | 1976-11-15 |
| DE2621276C2 (fr) | 1988-05-11 |
| HK86779A (en) | 1979-12-28 |
| NL7604429A (nl) | 1976-11-16 |
| DK145347C (da) | 1983-05-02 |
| JPS6345645B2 (fr) | 1988-09-12 |
| CY1034A (en) | 1980-08-01 |
| US4017360A (en) | 1977-04-12 |
| AU1361976A (en) | 1977-11-10 |
| DE2621276A1 (de) | 1976-11-25 |
| CA1066191A (fr) | 1979-11-13 |
| GB1488774A (en) | 1977-10-12 |
| AU504454B2 (en) | 1979-10-18 |
| JPS51139619A (en) | 1976-12-02 |
| DK190776A (da) | 1976-11-15 |
| CH629668A5 (de) | 1982-05-14 |
| NL188621B (nl) | 1992-03-16 |
| DK145347B (da) | 1982-11-01 |
| JPS58180432A (ja) | 1983-10-21 |
| JPS6112894B2 (fr) | 1986-04-10 |
| NL188621C (nl) | 1992-08-17 |
| ES447858A1 (es) | 1977-07-16 |
| FR2315947A1 (fr) | 1977-01-28 |
| FR2315947B1 (fr) | 1979-03-30 |
| SE431161B (sv) | 1984-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL47177A (en) | Antipregnancy vaccine | |
| ATA971076A (de) | Erbizide zubereitungen | |
| SE418053B (sv) | Oral beredning | |
| FR2315947A1 (fr) | Vaccin contre l'hepatite b | |
| DOP1976002544A (es) | Derivados peptidicos | |
| DK322876A (da) | Kebeimplantat | |
| DK454176A (da) | Galeniske preparater | |
| SE7601470L (sv) | Enossalt implantat | |
| BE832733A (nl) | Ritssluiting | |
| DK153811C (da) | Rodenticidt praeparat | |
| AU505999B2 (en) | Hepatitis vaccine | |
| FR2336918A1 (fr) | Amalgames dentaires | |
| SE7800781L (sv) | Nytt vaccin | |
| SE414700B (sv) | Artikulator | |
| SE7512782L (sv) | Forbettrad urokinasframstellning | |
| IT1057702B (it) | Manipolo dentistico | |
| IT1071275B (it) | Manipolo dentistico | |
| SE7813201L (sv) | Vaccin | |
| DK383079A (da) | Vaccine | |
| BE844143A (fr) | N-amides w -disubstitues d'acides amino-alcanoiques | |
| DK348476A (da) | Veskeopvarmningsapparat | |
| FR2298591A1 (fr) | Solution aque | |
| BE850141A (fr) | Vaccin | |
| SE7603745L (sv) | Bag | |
| AT363883B (de) | Reissverschluss |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: MERCK & CO. INC. Effective date: 19950531 |